You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase
|
---|---|
Published in |
Journal of Translational Medicine, February 2015
|
DOI | 10.1186/s12967-015-0435-y |
Pubmed ID | |
Authors |
Huiyuan Chen, Xinyi Li, Wenbin Li, Huyong Zheng |
Abstract |
Currently, O6-methylguanine-DNA methyltransferase(MGMT) promoter methylation is the most convincing predictive biomarker for temozolomide (TMZ) response in patients with glioblastoma multiforme (GBM). However, technical obstacles prevent this biomarker from being applied widely. On the other hand, microRNAs (miRNAs) are easily investigated in the clinical setting using quantitative real-time polymerase chain reactions. This study aimed to identify miRNAs that could serve as predictive biomarkers for TMZ response. |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 2 | 40% |
Unknown | 3 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Scientists | 2 | 40% |
Mendeley readers
The data shown below were compiled from readership statistics for 41 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 1 | 2% |
Unknown | 40 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 22% |
Student > Ph. D. Student | 7 | 17% |
Student > Master | 6 | 15% |
Other | 3 | 7% |
Student > Doctoral Student | 2 | 5% |
Other | 8 | 20% |
Unknown | 6 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 32% |
Biochemistry, Genetics and Molecular Biology | 10 | 24% |
Agricultural and Biological Sciences | 7 | 17% |
Unspecified | 1 | 2% |
Business, Management and Accounting | 1 | 2% |
Other | 0 | 0% |
Unknown | 9 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 April 2015.
All research outputs
#14,217,957
of 22,792,160 outputs
Outputs from Journal of Translational Medicine
#1,780
of 3,988 outputs
Outputs of similar age
#133,590
of 255,034 outputs
Outputs of similar age from Journal of Translational Medicine
#37
of 81 outputs
Altmetric has tracked 22,792,160 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,988 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 255,034 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.